Suullinen kysymys Lääkealan turvallisuus- ja kehittämiskeskus Fimeasta (Stefan Wallin r)

This oral question concerns the Finnish Medicines Agency (Fimea), specifically regarding its regionalization, personnel, and regional policy. It seeks clarification on the agency's operational structure and its impact on regional development. The question affects Fimea's staff and potentially the accessibility of its services across different regions in Finland. It also touches upon the broader implications for regional policy and drug regulation.